- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00552331
Evaluation of the Effects of Less Invasive Stabilization System (LISS) Plating Techniques in Distal Femoral Fractures
June 27, 2011 updated by: Nova Scotia Health Authority
Prospective Randomized Clinical Study to Evaluate the Effects of Less Invasive Stabilization System (LISS) Plating Techniques in Distal Femoral Fractures
The purpose of this study is to determine whether the rate of fracture healing and fracture union, repaired with the LISS device, will be as good as or better than the usual fracture fixation systems.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 3A7
- QEII Health Sciences Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The patient has read and agree to the consent
- Patient is 16 years or older (bones have finished growing)
- The injury happened in the last 14 days
Exclusion Criteria:
- The patient taking part in another study
- The patient has an infection at the operative site
- The patient has a health condition that affects bone healing or interferes with their ability to complete the study requirements (questionnaires, examinations), for example Paget's disease or osteomalacia
- The patient is taking medication that affects bone healing (such as systemic steroids)
- The patient has malignant (tumor) disease
- The patient is unable to attend follow-up clinic visits
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: LISS
Treatment of distal femur fracture with less invasive stabilization system
|
treatment of distal femur fractures with less invasive stabilization systems
|
|
Active Comparator: Standard Treatment
Treatment of distal femoral fractures using locking condylar plates or dynamic condylar screws
|
use of dynamic condylar screws or locking condylar plates in the treatment of distal femur fractures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Delayed union or nonunion of the distal femur
Time Frame: 12 months post operative
|
Determined via radiographic analysis
|
12 months post operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of adverse events
Time Frame: 12 months
|
12 months
|
|
|
Time to clinical healing
Time Frame: 12 months
|
assessed by weight-bearing ability and pain
|
12 months
|
|
Function as assessed by patient
Time Frame: 6 months, 12 months
|
Assessed using LEM, SMFA, and SF-36 questionnaires
|
6 months, 12 months
|
|
Range of motion
Time Frame: Post-op, 6 weeks, 3 months, 6 months, 12 months
|
Post-op, 6 weeks, 3 months, 6 months, 12 months
|
|
|
Gait analysis
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ross K Leighton, MD, FRCS(C), Capital Health, Canada
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2003
Primary Completion (Actual)
July 1, 2009
Study Completion (Actual)
July 1, 2009
Study Registration Dates
First Submitted
October 30, 2007
First Submitted That Met QC Criteria
October 30, 2007
First Posted (Estimate)
November 1, 2007
Study Record Updates
Last Update Posted (Estimate)
June 28, 2011
Last Update Submitted That Met QC Criteria
June 27, 2011
Last Verified
May 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDHA-RL-003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.